about
Brugada syndrome in the elderly.Safe single-dose administration of propofol in patients with established Brugada syndrome: a retrospective database analysis.Clinical characteristics, management, and prognosis of elderly patients with Brugada syndrome.The clinical impact of ajmaline challenge in elderly patients with suspected atrioventricular conduction disease.Drug-induced brugada syndrome in children: clinical features, device-based management, and long-term follow-up.The clinical significance of pregnancy in Brugada syndrome.Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.Clinical characterisation and long-term prognosis of women with Brugada syndrome.A score model to predict risk of events in patients with Brugada Syndrome.Long-term prognosis of drug-induced Brugada syndrome.Clinical utility of routine use of continuous transesophageal echocardiography monitoring during transvenous lead extraction procedure.High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.Antiplatelet therapy in acute coronary syndromes.Long-Term Trends in Newly Diagnosed Brugada Syndrome: Implications for Risk Stratification.Lay persons alerted by mobile application system initiate earlier cardio-pulmonary resuscitation: A comparison with SMS-based system notification.Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience.'The role of novel oral anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation'.Usefulness of P-Wave Duration and Morphologic Variability to Identify Patients Prone to Paroxysmal Atrial Fibrillation.Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience.True idiopathic ventricular fibrillation in out-of-hospital cardiac arrest survivors in the Swiss Canton Ticino: prevalence, clinical features, and long-term follow-up.On the Quest for the Best Freeze: Predictors of Late Pulmonary Vein Reconnections After Second-Generation Cryoballoon Ablation.Temporal trends and long term follow-up of implantable cardioverter defibrillator therapy for secondary prevention: A 15-year single-centre experience.Evaluation of the use of unipolar voltage amplitudes for detection of myocardial scar assessed by cardiac magnetic resonance imaging in heart failure patientsPersistence of Phrenic Nerve Palsy Following 28-mm Cryoballoon Ablation: A Four-Year Single Center Experience.Risk factors for incident depression in patients at first acute coronary syndrome.Single 3-minute freeze for second-generation cryoballoon ablation: one-year follow-up after pulmonary vein isolation.The challenges of performing ajmaline challenge in children with suspected Brugada syndrome.One year incidence of iatrogenic atrial septal defect after cryoballoon ablation for atrial fibrillation.Impact of transseptal puncture site on acute and mid-term outcomes during cryoballoon ablation: a comparison between anterior, medial and posterior transatrial access.[A case of electrical storm in a patient with short-coupled variant of torsade de pointes].Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis.Initial experience of three-minute freeze cycles using the second-generation cryoballoon ablation: acute and short-term procedural outcomes.Pulmonary vein isolation in patients with Brugada syndrome and atrial fibrillation: a 2-year follow-up.Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon.Age of First Arrhythmic Event in Brugada Syndrome: Data From the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 Patients.P-wave indices as predictors of atrial fibrillation recurrence after pulmonary vein isolation in normal left atrial size.Ice vs. fire: cryoballoon ablation for the prevention of inappropriate implantable cardioverter-defibrillator shocks in a 14-year-old girl with Brugada syndrome.Type D personality in never depressed patients at their first acute coronary syndrome.Single freeze strategy with the second- generation cryballoon for atrial fibrillation: a multicenter international retrospective analysis in a large cohort of patients.Type D personality in never-depressed patients and the development of major and minor depression after acute coronary syndrome.
P50
Q33162103-02404D84-CDBA-4273-B3FC-1CDC6380BEA4Q33163163-D780F997-2E6C-45C4-93AE-5B41B6C4295AQ33163709-4AFFBF90-6E07-4A55-A688-B999C9948F48Q33163775-3D64C186-DB69-4144-9885-93ACD7A20515Q33164037-E54F9EB7-FB3A-4376-8F33-2CA888068BE5Q33164214-3CB2E04B-2D4E-41FB-B24E-AB821DB91BC2Q33165377-F92959C7-D70D-4E08-898E-B90DD4976A32Q33166655-1A860E5A-75F2-4068-BFBF-7CAA1036B0A8Q33168502-AB9F423E-9A66-4919-A88A-56DE5E3927E1Q33168592-0164C3A9-8BBA-4EF9-BE6F-65A5CBFB48F0Q35328130-11C11C22-C8DD-45D0-B6CA-A55E72798934Q36015217-F5E9DFF8-1340-4C6E-84CC-0D31BF5642CEQ37965609-649A8FF9-7DB5-4BF7-93F6-BDBD5698614AQ38834462-B182D30A-028A-45BA-9417-7ACE2E6BEA34Q38924538-0B87BE1C-6F54-40D4-9769-5124D49CA5AEQ39014965-3B1C9898-35D8-488E-AB39-AC567D98CE10Q39021349-D87E1E53-08AD-40BA-8E17-381A5B7D0FE8Q39205912-2EB9A7A2-04D1-487E-AFD1-7228E9A46E5CQ39985226-62DE7F44-C7C4-4326-865E-5649BB42A855Q40345445-90B132ED-8735-44C9-9A3F-E027BAB8DBBEQ40363557-685DAF0E-55C4-48E3-9452-5BA760DD1BE8Q40468089-678BE3D4-C7D9-4415-B18F-FBEAB8BEB32AQ40959685-95015A99-F395-491F-9195-A25CF3A6F09BQ41103694-907B950F-C975-4C63-B43A-F170B744E76BQ41611461-D1B1BCD8-C53F-4084-BB12-3679E141DB9AQ41647228-F5FE2A05-7F12-4EB8-B9BE-477512FF7B2DQ42943075-C5721EFD-60E7-4778-9A2A-2DB86AE21797Q43644309-FF8327C5-F8AD-44EF-AC85-F5977D2B1388Q44094519-F69845CD-B925-4744-B816-635D417BD2CBQ44102833-1EA1805D-01BF-464A-85C8-356A04D9AD97Q44189708-AA3D8581-22A4-40EE-9588-C06B7B3A4974Q44283442-374A1C0D-9EFA-41FB-A501-38C8B9F5141AQ45223897-DB639AA1-891F-4058-B02C-092FAE335770Q45419795-7C230A36-7D46-49F9-89AC-81C04E6ADDBFQ47236998-1E7F2F26-1BCD-4B25-9353-EED459BC5961Q47419619-C751E149-E131-41DA-896E-8743BD246202Q47764440-3361F30F-BC8E-4C82-9D30-D2D73C2DF17AQ48309446-96DC1EC9-E4F7-4954-BB57-4D53E32D9D95Q48338684-8665EA1F-BAB0-4605-B867-732EFBA538CDQ48395633-279C00AC-937A-49EF-9E08-D1BC7EC0545D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giulio Conte
@ast
Giulio Conte
@en
Giulio Conte
@es
Giulio Conte
@nl
Giulio Conte
@sl
type
label
Giulio Conte
@ast
Giulio Conte
@en
Giulio Conte
@es
Giulio Conte
@nl
Giulio Conte
@sl
altLabel
M.D.; Ph.D.
@en
prefLabel
Giulio Conte
@ast
Giulio Conte
@en
Giulio Conte
@es
Giulio Conte
@nl
Giulio Conte
@sl
P106
P21
P31
P496
0000-0003-2248-3456